Tonix Pharmaceuticals Holding Corp. has announced the entry into a Sales Agreement with A.G.P./Alliance Global Partners, allowing the company to offer and sell up to $150 million of its common stock through A.G.P. as a sales agent. The agreement does not obligate the company to sell any shares but permits sales to be made at the company's discretion, consistent with applicable laws and regulations. Additionally, Tonix has entered into a Purchase Agreement with Lincoln Park Capital Fund, LLC, enabling the sale of up to $75 million of newly issued shares of common stock. These agreements provide Tonix with the flexibility to raise capital as needed to support its operations and strategic initiatives.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。